Home › Calculator › GLAXF Dividend Calculator 2026
GLAXF Dividend DRIP Calculator 2026
3.48% YieldHealthcareGSK plc · OTC
Price: $25.77 · Annual div: $0.90/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When GLAXF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your GLAXF snowball 📈
$10,000 in GLAXF → $5.8K in 10 years · $0.32/month
About GSK plc (GLAXF) — Dividend Analysis 2026
GSK plc, a global healthcare and pharmaceutical leader with roots tracing back to 1715, is headquartered in Brentford, United Kingdom. Operating extensively across the UK, United States, and other international markets, its activities span the entire lifecycle of healthcare products, encompassing research, development, manufacturing, and commercialization. Its broad portfolio includes pharmaceuticals, vaccines, over-the-counter medications, and a range of health-focused consumer products. The company operates through four primary divisions: Pharmaceuticals, Pharmaceutical Research & Development, Vaccines, and Consumer Healthcare. Within its pharmaceutical arm, GSK provides therapeutic solutions for a broad spectrum of conditions. These include ailments in respiratory health, HIV, immuno-inflammation, oncology, viral infections, central nervous system disorders, cardiovascular and urogenital issues, metabolic diseases, bacterial infections, and dermatology. The consumer healthcare division delivers products across wellness, oral health, nutrition, and skin health categories. These are available in numerous formats, including nasal sprays, tablets, syrups, lozenges, gum and transdermal patches, caplets, infant syrup drops, liquid suspensions, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams, non-medicated patches, lip balms, gummies, and soft chews. GSK also maintains collaborative agreements with various organizations such as 23andMe, Lyell Immunopharma, Inc., Novartis, Sanofi SA, Surface Oncology, Progentec Diagnostics, Inc., Alector, Inc., and CureVac AG. Furthermore, strategic partnerships are in place with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The firm, known as GlaxoSmithKline plc until its name change to GSK plc in May 2022, embodies centuries of innovation in healthcare.
Compare GLAXF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full GLAXF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GLAXF position with:
🌍 GLAXF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold GLAXF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3.48% | 0.68% | $348 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.96% | 0.16% | $296 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.78% | -0.02% | $278 / yr |
| 🇬🇧 UK ISA | 0% | 3.48% | 0.68% | $348 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.18% | 0.38% | $318 / yr |
| 🇨🇦 TFSA | 0% | 3.48% | 0.68% | $348 / yr |
| 🇨🇦 CA Taxable | 25% | 2.61% | -0.19% | $261 / yr |
| 🇦🇺 Super (pension) | 15% | 2.96% | 0.16% | $296 / yr |
| 🇦🇺 AU Taxable | 30% | 2.44% | -0.36% | $244 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.56% | -0.24% | $256 / yr |
| 🇫🇷 FR Taxable | 30% | 2.44% | -0.36% | $244 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 GLAXF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.90/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 GLAXF Dividend Payment Schedule
GLAXF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 GLAXF vs Healthcare Benchmarks
How GLAXF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GLAXF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ GLAXF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where GLAXF earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GLAXF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
GSK plc (GLAXF) is currently trading at $25.77, 8% below its 52-week high. The current dividend yield is 3.48% based on an annual payout of $0.90 per share.
GLAXF (GSK plc) — 3.48% Dividend Yield Analysis
GSK plc (GLAXF) is a healthcare stock currently trading at $25.77 with a dividend yield of 3.48%. The company pays an annual dividend of $0.90 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, GLAXF has grown its dividend at a compound annual rate of 36.7%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest GLAXF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.